FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

819963008: Brolucizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2020. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3858363017 Brolucizumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3858364011 Brolucizumab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Brolucizumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Brolucizumab Has disposition Vascular endothelial growth factor receptor antagonist true Inferred relationship Existential restriction modifier
Brolucizumab Is a Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) true Inferred relationship Existential restriction modifier
Brolucizumab Is a Substance with Janus kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Brolucizumab Has active ingredient True Brolucizumab Inferred relationship Existential restriction modifier 1
Product containing brolucizumab (medicinal product) Has active ingredient True Brolucizumab Inferred relationship Existential restriction modifier 1
Product containing brolucizumab in parenteral dose form (medicinal product form) Has active ingredient True Brolucizumab Inferred relationship Existential restriction modifier 1
Product containing only brolucizumab in parenteral dose form (medicinal product form) Has active ingredient True Brolucizumab Inferred relationship Existential restriction modifier 1
Product containing precisely brolucizumab 120 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Brolucizumab Inferred relationship Existential restriction modifier 1
Product containing precisely brolucizumab 120 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Brolucizumab Inferred relationship Existential restriction modifier 1
Beovu 19.8mg/0.165ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Brolucizumab Inferred relationship Existential restriction modifier
Brolucizumab 19.8mg/0.165ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Brolucizumab Inferred relationship Existential restriction modifier
Brolucizumab 19.8mg/0.165ml solution for injection pre-filled syringes Has specific active ingredient True Brolucizumab Inferred relationship Existential restriction modifier
Beovu 19.8mg/0.165ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) 1 pre-filled disposable injection Has specific active ingredient True Brolucizumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start